Researchers have begun enrolling patients in newly launched clinical trials involving a blood pressure medication, losartan, as a potential treatment for those recently diagnosed with COVID-19. Both studies are multi-site trials, one for patients requiring hospitalization and the other for diagnosed patients who do not require a hospital stay.
Other News
Colin Tang-Whitmore started volunteering with the Mobile Health Initiative during his first year of medical school.
The competition has grown into a nationwide initiative, fostering collaboration across disciplines and universities.